Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes

Authors

  • Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, Mohali, India;
  • Suneet Verma Department of Medicine, Alchemist Hospital, Panchkula, India;
  • Nitin Kapoor Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; Non-communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

DOI:

https://doi.org/10.47391/JPMA.24-89

Abstract

This brief communication describes the concept of physiofriendly
pharmacotherapy for type 2 diabetes mellitus.
Physio-friendly therapy is defined as that which restores
metabolic, including glycaemic and weight homoeostasis,
to near normal levels. Drugs such as glucagon like
peptide 1 receptor agonists (GLP1RA), sodium glucose cotransporter-
2 inhibitors (SGLT2i), and alfa glucosidase
inhibitors, along with metformin, work in a physio-friendly
manner and may facilitate remission. Thus, they can also be
termed as remission-facilitating drugs.
Keywords: Diabetes, relapse, remission, person centred
care, type 2 diabetes

Downloads

Published

2024-10-16

How to Cite

Sanjay Kalra, Suneet Verma, & Nitin Kapoor. (2024). Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes. Journal of the Pakistan Medical Association, 74(11), 2012–2013. https://doi.org/10.47391/JPMA.24-89

Issue

Vol. 74 No. 11 (2024): NOVEMBER

Section

RECENT ADVANCES IN ENDOCRINOLOGY

License

Copyright (c) 2024 Journal of the Pakistan Medical Association

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.